|
covid-19 |
19 |
|
neoadjuvant therapy |
13 |
|
thyroiditis |
12 |
|
esophageal squamous cell carcinoma |
11 |
|
sars-cov-2 |
11 |
|
thyroid function tests |
11 |
|
thyroid gland |
11 |
|
hepatocellular carcinoma |
10 |
|
prognosis |
10 |
|
chest x-ray |
9 |
|
deep learning |
9 |
|
nomogram |
9 |
|
prediction model |
9 |
|
white cell count |
9 |
|
18f-fdg pet |
8 |
|
chemoradiotherapy |
8 |
|
longitudinal real-time monitoring |
8 |
|
non-invasive biomarker |
8 |
|
oesophageal cancer |
8 |
|
oesophageal squamous cell carcinoma |
8 |
|
oesophagectomy |
8 |
|
radiomics |
8 |
|
advanced escc |
7 |
|
alkaline phosphatase |
7 |
|
azygos vein blood |
7 |
|
biliary |
7 |
|
cell-free dna |
7 |
|
cholangiogram |
7 |
|
circulating tumor cells |
7 |
|
circulating tumor cells (ctc) |
7 |
|
ctc clusters |
7 |
|
ctc enumeration |
7 |
|
curriculum |
7 |
|
early prediction |
7 |
|
emt |
7 |
|
epithelioid |
7 |
|
gestational |
7 |
|
ketamine |
7 |
|
liquid biopsy |
7 |
|
magnetic resonance cholangiography |
7 |
|
medical students |
7 |
|
substance abuse |
7 |
|
trophoblastic |
7 |
|
tumors |
7 |
|
computed tomography |
6 |
|
neoadjuvant chemoradiotherapy |
6 |
|
radiogenomic |
6 |
|
5-fluorouracil |
5 |
|
[11c]-acetate |
5 |
|
capecitabine |
5 |
|
cervical cancer |
5 |
|
cetuximab |
5 |
|
chinese |
5 |
|
contrast-enhanced ct |
5 |
|
diffusion-weighted imaging |
5 |
|
fluorine-18-fluorodeoxyglucose |
5 |
|
head and neck cancer |
5 |
|
hypoxia |
5 |
|
imbalanced datasets |
5 |
|
interval debulking surgery |
5 |
|
intravoxel incoherent motion |
5 |
|
lymph node metastasis |
5 |
|
magnetic resonance imaging |
5 |
|
metastatic colorectal cancer |
5 |
|
neo-adjuvant chemotherapy |
5 |
|
ovarian cancer |
5 |
|
pet imaging |
5 |
|
positron-emission tomography |
5 |
|
re-sampling techniques |
5 |
|
rna sequencing |
5 |
|
survival |
5 |
|
treatment outcome |
5 |
|
ultrasound |
5 |
|
ablation techniques |
4 |
|
artificial intelligence |
4 |
|
checkpoint inhibitor |
4 |
|
chest radiographs |
4 |
|
diffusion magnetic resonance imaging |
4 |
|
hands-on training |
4 |
|
hcc |
4 |
|
high-intensity focused ultrasound ablation |
4 |
|
immunotherapy |
4 |
|
interventional ultrasonography |
4 |
|
learning |
4 |
|
neoplasm, residual |
4 |
|
nodular goiter |
4 |
|
ovarian neoplasms |
4 |
|
peritoneal neoplasms |
4 |
|
pneumonia |
4 |
|
point-of-care ultrasound |
4 |
|
stereotactic ablative radiation therapy |
4 |
|
stereotactic radiation therapy |
4 |
|
teaching |
4 |
|
ultrasonography |
4 |
|
18f-fdg pet/ct |
3 |
|
complete metabolic response |
3 |
|
fluorodeoxyglucose f 18 |
3 |
|
hernia |
3 |
|
management |
3 |
|
measurement |
3 |
|
mri |
3 |
|
ovarian and peritoneal cancers |
3 |
|
palliative |
3 |
|
peritoneal carcinomatosis |
3 |
|
response criteria |
3 |
|
run length |
3 |
|
systemic therapy |
3 |
|
texture analysis |
3 |
|
tumor debulking |
3 |
|
68ga |
2 |
|
anti-thyroglobulin autoantibody |
2 |
|
anticoagulants |
2 |
|
benign thyroid nodule |
2 |
|
bowel |
2 |
|
dota |
2 |
|
drain |
2 |
|
focused ultrasound |
2 |
|
graves’ disease |
2 |
|
hemorrhage |
2 |
|
hypothyroidism |
2 |
|
induced hyperthermia |
2 |
|
inguinal |
2 |
|
laparoscopic |
2 |
|
marker |
2 |
|
neuroendocrine tumors |
2 |
|
nodular goitre |
2 |
|
nodule shrinkage |
2 |
|
pain management |
2 |
|
peptide receptor radionuclide therapy |
2 |
|
pet/ct |
2 |
|
platelet aggregation inhibitors |
2 |
|
recurrent laryngeal nerve |
2 |
|
seroma |
2 |
|
thermal ablation |
2 |
|
thyroglobulin |
2 |
|
thyroid dysfunction |
2 |
|
thyroid nodule |
2 |
|
thyroidectomy |
2 |
|
thyrotoxicosis |
2 |
|
treatment efficacy |
2 |
|
ultrasonic imaging |
2 |
|
ultrasound imaging |
2 |
|
vocal cord palsy |
2 |
|
abdominal aortic aneurysm screening |
1 |
|
abscess |
1 |
|
anatomical open surgical management |
1 |
|
artificial intelligence and machine learning |
1 |
|
atherosclerotic aorto-iliac occlusive disease |
1 |
|
biliary obstruction |
1 |
|
blood flow |
1 |
|
cancer signature |
1 |
|
chemotherapy |
1 |
|
cholangitis |
1 |
|
clinical decision support |
1 |
|
coagulation |
1 |
|
contrast enhanced ultrasound (ceus) |
1 |
|
contrast-enhanced sonography |
1 |
|
critical care |
1 |
|
ct |
1 |
|
deep vein |
1 |
|
diagnostic imaging |
1 |
|
doppler ultrasound |
1 |
|
duodenal obstruction |
1 |
|
ear / nose / throat |
1 |
|
electronic health record |
1 |
|
empyema |
1 |
|
endoscopy |
1 |
|
enteral feeding |
1 |
|
eosinophilic gastroenteritis |
1 |
|
fluid collection |
1 |
|
geriatrics |
1 |
|
groin |
1 |
|
iatrogenic oeosphageal perforation |
1 |
|
image guidance |
1 |
|
incidence |
1 |
|
isolated pancreatic metastases |
1 |
|
liver disease |
1 |
|
liver transplantation |
1 |
|
microbubble contrast agents |
1 |
|
ontology |
1 |
|
palliative treatment |
1 |
|
percutaneous cholecystostomy |
1 |
|
pet |
1 |
|
pulmonary embolism |
1 |
|
redo-nissen fundiplication |
1 |
|
renal cell carcinoma |
1 |
|
repeatability, accuracy |
1 |
|
reproducibility |
1 |
|
snomed |
1 |
|
stents |
1 |
|
targeted therapy |
1 |
|
temporary self-expanding removable metallic stent |
1 |
|
ultrasound measurements |
1 |
